News archive

There is a large, untapped potential for developing drugs against cancer, fibrosis and cardiovascular diseases by targeting a family of receptors known as Frizzleds, researchers at Karolinska Institutet in Sweden believe. In a new study published in Science Signaling, they identify how these receptors are activated in the cell membrane and the processes that are then triggered within the cell.

Eight projects at Karolinska Institutet have been awarded the recently established KI Engagement Grants, which aim to help KI researchers get started along a path to societal impact. These grants are part of an internal ‘impact and outreach’ effort approved by KI President Ole Petter Ottersen.

.

Margareta Wilhelm at MTC was awarded a highly competitive Senior Research position from the Board of Research at Karolinska Institutet. She will receive 1.2 million SEK per year over five years to be used for salary.

Four out of eight grants awarded to Karolinska Institutet from the Swedish Research Council within the area of Humanities and Social sciences was given to researchers at the Division of Aging Research Center (ARC) at the Department of Neurobiology, Care Sciences and Society (NVS).

Pneumococci are the most common cause of respiratory tract infections, such as otitis and sinusitis, as well as of severe infections like pneumonia and meningitis. A new study from Karolinska Institutet published in Nature Microbiology shows how the bacteria can inhibit immune cell reaction and survive inside cells to give rise to pneumonia.

Professor Juleen R. Zierath and Maléne E. Lindholm are the recipients of two prestigious awards presented at the 17th International Biochemistry of Exercise Conference (IBEC) which took place between October 23-25, 2018, in Beijing, China.